Codiak Biosciences Lines up for $86 Million IPO 0 01.05.2019 03:00 Feedity.com The company is banking on investors approving of its approach to harness exosomes, which had once been considered the cells’ garbage cans, as a means of pioneering a new class of biologic medicines. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
